Kim YM - Search Results

1

Assessment of mitophagy in mt-Keima Drosophila revealed an essential role of the PINK1-Parkin pathway in mitophagy induction in vivo.

Kim YY, Um JH, Yoon JH, Kim H, Lee DY, Lee YJ, Jee HJ, Kim YM, Jang JS, Jang YG, Chung J, Park HT, Finkel T, Koh H, Yun J. Kim YY, et al. Among authors: kim h, kim ym. FASEB J. 2019 Sep;33(9):9742-9751. doi: 10.1096/fj.201900073R. Epub 2019 May 23. FASEB J. 2019. PMID: 31120803

2

Cooperation between p21 and Akt is required for p53-dependent cellular senescence.

Kim YY, Jee HJ, Um JH, Kim YM, Bae SS, Yun J. Kim YY, et al. Among authors: kim ym. Aging Cell. 2017 Oct;16(5):1094-1103. doi: 10.1111/acel.12639. Epub 2017 Jul 9. Aging Cell. 2017. PMID: 28691365 Free PMC article.

3

Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy.

Lee Y, Kim IH, Kim J, Yoon JH, Shin YH, Jung Y, Kim YM. Lee Y, et al. Among authors: kim ih, kim ym, kim j. J Drug Target. 2011 Jun;19(5):336-43. doi: 10.3109/1061186X.2010.499462. Epub 2010 Jul 8. J Drug Target. 2011. PMID: 20615092

4

N-succinylaspart-1-yl celecoxib is a potential colon-specific prodrug of celecoxib with improved therapeutic properties.

Lee Y, Kim J, Kim H, Kang S, Yoon JH, Kim DD, Kim YM, Jung Y. Lee Y, et al. Among authors: kim dd, kim h, kim ym, kim j. J Pharm Sci. 2012 May;101(5):1831-42. doi: 10.1002/jps.23082. Epub 2012 Feb 14. J Pharm Sci. 2012. PMID: 22334096

5

Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.

Hong S, Yum S, Yoo HJ, Kang S, Yoon JH, Min D, Kim YM, Jung Y. Hong S, et al. Among authors: kim ym. Mol Pharm. 2012 May 7;9(5):1310-9. doi: 10.1021/mp200591q. Epub 2012 Mar 27. Mol Pharm. 2012. PMID: 22428658

6

Structural effects of N-aromatic acyl-amino acid conjugates on their deconjugation in the cecal contents of rats: implication in design of a colon-specific prodrug with controlled conversion rate at the target site.

Kong H, Kim H, Do H, Lee Y, Hong S, Yoon JH, Jung Y, Kim YM. Kong H, et al. Among authors: kim h, kim ym. Biopharm Drug Dispos. 2011 Sep;32(6):343-54. doi: 10.1002/bdd.763. Epub 2011 Jul 29. Biopharm Drug Dispos. 2011. PMID: 21800327

7

Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole.

Kim H, Lee Y, Yoo H, Kim J, Kong H, Yoon JH, Jung Y, Kim YM. Kim H, et al. Among authors: kim ym, kim j. J Drug Target. 2012 Apr;20(3):255-63. doi: 10.3109/1061186X.2011.639024. Epub 2011 Nov 26. J Drug Target. 2012. PMID: 22118327

8

Susceptibility of glucocorticoids to colonic metabolism and pharmacologic intervention in the metabolism: implication for therapeutic activity of colon-specific glucocorticoid 21-sulfate sodium at the target site.

Kong H, Lee Y, Kim H, Hong S, Kim DD, Yoon JH, Jung Y, Kim YM. Kong H, et al. Among authors: kim dd, kim h, kim ym. J Pharm Pharmacol. 2012 Jan;64(1):128-38. doi: 10.1111/j.2042-7158.2011.01386.x. Epub 2011 Nov 18. J Pharm Pharmacol. 2012. PMID: 22150680

9

Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.

Jung Y, Kim HH, Kim H, Kong H, Choi B, Yang Y, Kim Y. Jung Y, et al. Eur J Pharm Sci. 2006 May;28(1-2):26-33. doi: 10.1016/j.ejps.2005.12.005. Epub 2006 Feb 7. Eur J Pharm Sci. 2006. PMID: 16455235

10

[The experiences of mental health hospital workers].

Kim YH, Chang KO, Koo MJ, Kim SH, Kim YM, Lee NY. Kim YH, et al. Among authors: kim ym, kim sh. Taehan Kanho Hakhoe Chi. 2007 Apr;37(3):381-90. doi: 10.4040/jkan.2007.37.3.381. Taehan Kanho Hakhoe Chi. 2007. PMID: 17615459 Korean.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,102 results

Search Page

Filters